687 related articles for article (PubMed ID: 18757150)
1. Utility of cyclodextrins in the formulation of genistein part 1. Preparation and physicochemical properties of genistein complexes with native cyclodextrins.
Daruházi AE; Szente L; Balogh B; Mátyus P; Béni S; Takács M; Gergely A; Horváth P; Szoke E; Lemberkovics E
J Pharm Biomed Anal; 2008 Nov; 48(3):636-40. PubMed ID: 18757150
[TBL] [Abstract][Full Text] [Related]
2. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line.
Daruházi AE; Kiss T; Vecsernyés M; Szente L; Szőke E; Lemberkovics E
J Pharm Biomed Anal; 2013 Oct; 84():112-6. PubMed ID: 23810850
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
4. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
[TBL] [Abstract][Full Text] [Related]
5. Enhanced bioavailability of soy isoflavones by complexation with beta-cyclodextrin in rats.
Lee SH; Kim YH; Yu HJ; Cho NS; Kim TH; Kim DC; Chung CB; Hwang YI; Kim KH
Biosci Biotechnol Biochem; 2007 Dec; 71(12):2927-33. PubMed ID: 18071265
[TBL] [Abstract][Full Text] [Related]
6. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Wang S; Ding Y; Yao Y
Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical [corrected] properties of the inclusion complex of puerarin and glucosyl-β-cyclodextrin.
Liu B; Zhao J; Liu Y; Zhu X; Zeng J
J Agric Food Chem; 2012 Dec; 60(51):12501-7. PubMed ID: 23215052
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the 2:1 molecular recognition and inclusion behaviour between beta- and gamma-cyclodextrins and cinchonine.
Wen X; Liu Z; Zhu T; Zhu M; Jiang K; Huang Q
Bioorg Chem; 2004 Aug; 32(4):223-33. PubMed ID: 15210337
[TBL] [Abstract][Full Text] [Related]
9. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of vorinostat by cyclodextrins.
Cai YY; Yap CW; Wang Z; Ho PC; Chan SY; Ng KY; Ge ZG; Lin HS
J Clin Pharm Ther; 2010 Oct; 35(5):521-6. PubMed ID: 20831676
[TBL] [Abstract][Full Text] [Related]
11. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
Kopecký F; Kopecká B; Kaclík P
Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of drug solubility in supramolecular and colloidal systems.
Süle A; Szente L; Csempesz F
J Pharm Sci; 2009 Feb; 98(2):484-94. PubMed ID: 18506803
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Physicochemical Characterization of an Inclusion Complex Between Dimethylated β-Cyclodextrin and a Drug Lead From a New Class of Orally Active Antimalarial 3,5-Diaryl-2-Aminopyridines.
Joseph LM; Chibale K; Caira MR
J Pharm Sci; 2016 Nov; 105(11):3344-3350. PubMed ID: 27640751
[TBL] [Abstract][Full Text] [Related]
14. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
15. Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.
Mennini N; Bragagni M; Maestrelli F; Mura P
J Pharm Biomed Anal; 2014 Feb; 89():142-9. PubMed ID: 24291109
[TBL] [Abstract][Full Text] [Related]
16. Solubilization and stabilization of sodium dicloxacillin by cyclodextrin inclusion.
Echezarreta-López MM; Otero-Mazoy I; Ramírez HL; Villalonga R; Torres-Labandeira JJ
Curr Drug Discov Technol; 2008 Jun; 5(2):140-5. PubMed ID: 18673252
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
18. Molecular interactions of the inclusion complexes of hinokitiol and various cyclodextrins.
Suzuki R; Inoue Y; Limmatvapirat S; Murata I; Kanamoto I
AAPS PharmSciTech; 2017 Oct; 18(7):2717-2726. PubMed ID: 28299622
[TBL] [Abstract][Full Text] [Related]
19. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
